Cargando…
Oncostatin M is overexpressed in NASH‐related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis
Oncostatin M (OSM) is a pleiotropic cytokine of the interleukin (IL)‐6 family that contributes to the progression of chronic liver disease. Here we investigated the role of OSM in the development and progression of hepatocellular carcinoma (HCC) in non‐alcoholic fatty liver disease (NAFLD)/non‐alcoh...
Autores principales: | Di Maira, Giovanni, Foglia, Beatrice, Napione, Lucia, Turato, Cristian, Maggiora, Marina, Sutti, Salvatore, Novo, Erica, Alvaro, Maria, Autelli, Riccardo, Colombatto, Sebastiano, Bussolino, Federico, Carucci, Patrizia, Gaia, Silvia, Rosso, Chiara, Biasiolo, Alessandra, Pontisso, Patrizia, Bugianesi, Elisabetta, Albano, Emanuele, Marra, Fabio, Parola, Maurizio, Cannito, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315146/ https://www.ncbi.nlm.nih.gov/pubmed/35064579 http://dx.doi.org/10.1002/path.5871 |
Ejemplares similares
-
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation
por: Foglia, Beatrice, et al.
Publicado: (2021) -
Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts
por: Foglia, Beatrice, et al.
Publicado: (2019) -
SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease
por: Novo, Erica, et al.
Publicado: (2022) -
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors-1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets
por: Cannito, Stefania, et al.
Publicado: (2019) -
Inflammatory processes involved in NASH-related hepatocellular carcinoma
por: Cannito, Stefania, et al.
Publicado: (2023)